journal article·2025-04Open access

UiO-based platforms in biomedicine: Advanced nanovehicles for effective treatment

Ren Zhang, Abdulnasser Mahmoud Karami, Qianying Huang, Xueqi Tan, Awad Naser Albalwi, Jianqiang Liu, Irshad Ul Haq Bhat, Mohd Muddassir

Abstract

In current medical field, antimicrobial, anti-inflammatory, and anticancer treatments face many challenges. The increasing resistance of bacteria causes the efficacy of traditional antibacterial drugs to decrease gradually. The complex pathogenesis and chronic course of inflammatory diseases make treatment difficult. There are still some limitations to the treatment of cancer. Therefore, searching for an efficient and safe therapeutic strategies and materials has become urgent. Metal-organic framework (MOF) materials have attracted wide attention in antibacterial, anti-inflammatory and anticancer therapy due to their unique structure and diverse properties. UiO-based MOF (UiO = University of Oslo) is a representative class of MOF materials.These UiO-66 and UiO-67 have significant advantages and potential value in the treatment of bacterial infections, inflammatory diseases , and cancer due to their excellent stability, high specific surface area, and tunable structure. In antimicrobial therapy , UiO-based MOF can inhibit bacterial growth and spread in various ways. In anti-inflammatory therapy, inflammation-related signaling pathways can be regulated. Anti-cancer therapy has the role of targeting the delivery of anti-cancer drugs and enhancing the therapeutic effect. This paper systematically reviews the application of UiO-based MOFs in antibacterial, anti-inflammatory, and anticancer therapy. It also describes the use of artificial intelligence (AI) to predict the developing MOFs that will produce a family of UiO-based materials, discusses the challenges of UiO-based MOFs in biomedical applications, and looks ahead to future developments, suggesting that AI may drive further advances in biomedicine.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Molecular Communication and Nanonetworks · Innovative Microfluidic and Catalytic Techniques Innovation · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Bacterial infections, antimicrobial resistance and antibiotic therapy10.3390/life12040468 ↗
2. Residual antibiotics as an alarming health threat for human; A systematic study and meta-analysis in Iranian animal food products
3. Molecular foundations of inflammatory diseases: insights into inflammation and inflammasomes10.3390/cimb46010030 ↗
4. Inflammation and aging-related disease: a transdisciplinary inflammaging framework
5. Research progress in the application of non-steroidal anti-inflammatory drugs in the treatment of periodontitis
6. Changes and prospects of glucocorticoids in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis
7. Clinical trial of antibiotic combination therapy in elderly patients with Mycoplasma pneumoniae pneumoniae
8. Advances in the mechanism of photobiomodulation therapy for muscle dysfunction in chronic obstructive pulmonary disease
9. Chronic atrophic gastritis: a review10.1615/JEnvironPatholToxicolOncol.2018026839 ↗
10. Nanoparticulate drug delivery systems targeting inflammation for treatment of inflammatory bowel disease10.1016/j.nantod.2017.08.006 ↗
11. Local scaffold-assisted delivery of immunotherapeutic agents for improved cancer immunotherapy10.1016/j.addr.2022.114308 ↗
12. Targeted therapies for cancer10.1186/s12916-022-02287-3 ↗
13. Advances in clinical research of antibody-drug conjugates in targeted therapy for lung cancer
14. Nanotheranostic strategies for cancer immunotherapy10.1002/smtd.202200718 ↗
15. A review on cancer immunotherapy and applications of nanotechnology to chemoimmunotherapy of different cancers10.3390/molecules26113382 ↗
16. Photoactive MOF-derived bimetallic silver and cobalt nanocomposite with enhanced antibacterial activity10.1021/acsami.3c01529 ↗
17. A potent multifunctional ZIF-8 nanoplatform developed for colorectal cancer therapy by triple-delivery of chemo/radio/targeted therapy agents10.1039/D3TB02571C ↗
18. Perspectives on usage of functional nanomaterials in antimicrobial therapy for antibiotic-resistant bacterial infections10.1021/acsomega.3c00110 ↗
19. Functional porous Ce-UiO-66 MOF@Keratin composites for the efficient adsorption of trypan blue dye from wastewater: a step towards practical implementations10.1016/j.cej.2023.142103 ↗
20. Cerium based UiO-66 MOF as a multipollutant adsorbent for universal water purification10.1016/j.jhazmat.2021.125941 ↗
21. Preparation and photocatalytic performance of UiO-66/La-MOF composite10.2166/wst.2022.197 ↗
22. Stability and adsorption performance of UiO-67 for uranium (VI) in solution10.1007/s10967-023-09279-4 ↗
23. Integrated Zr-MOF/NH4TiOF3 bilayer coating on magnesium for controllable corrosion, cytocompatibility, and drug delivery multifunctionalities10.1002/admi.202201255 ↗
24. A comprehensive review on water remediation using UiO-66 MOFs and their derivatives10.1016/j.chemosphere.2022.134845 ↗
25. Novel approaches to the treatment of bacterial biofilm infections
26. Bioinspired nanomaterials for the treatment of bacterial infections10.1007/s12274-023-6283-9 ↗
27. Recent innovations in bacterial infection detection and treatment10.1021/acsinfecdis.0c00890 ↗
28. Beyond antibiotics: new therapeutic approaches for bacterial infections10.1093/cid/ciw200 ↗
29. Alpha-toxin of Staphylococcus aureus10.1128/mr.55.4.733-751.1991 ↗
30. Bacterial biofilms: a common cause of persistent infections10.1126/science.284.5418.1318 ↗
31. The involvement of cell-to-cell signals in the development of A bacterial biofilm10.1126/science.280.5361.295 ↗
32. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease10.1038/nrmicro1871 ↗
33. Antibacterial activities of flavonoids: structure-activity relationship and mechanism10.2174/0929867321666140916113443 ↗
34. Approved glycopeptide antibacterial drugs: mechanism of action and resistance, cold spring
35. Single atom nanozymes for bacterial infection therapy10.1039/D3BM01838E ↗
36. Emerging treatment options for multi-drug-resistant bacterial infections10.3390/life11060519 ↗
37. Phototherapy-based combination strategies for bacterial infection treatment10.7150/thno.52729 ↗
38. Metal nanoparticles for diagnosis and therapy of bacterial infection10.1002/adhm.201701392 ↗
39. An “On-site transformation” strategy for treatment of bacterial infection10.1002/adma.201703461 ↗
40. Stimuli-responsive NO delivery platforms for bacterial infection treatment
41. Inflammation, autoinflammation and autoimmunity in inflammatory bowel diseases10.3390/cimb45070350 ↗
42. Anti-inflammatory effects of glyceollins derived from soybean by elicitation with Aspergillus Sojae10.1007/s00011-011-0351-4 ↗
43. Natural products as A source of anti-inflammatory agents associated with inflammatory bowel disease10.3390/molecules18067253 ↗
44. Cowpea: an overview on its nutritionals facts and health benefits10.1002/jsfa.9074 ↗
45. Diet as A Trigger or therapy for inflammatory bowel diseases10.1053/j.gastro.2016.10.019 ↗
46. Origin and physiological roles of inflammation10.1038/nature07201 ↗
47. Processes of sterile inflammation10.4049/jimmunol.1301539 ↗
48. The third international consensus definitions for sepsis and septic shock (Sepsis-3)10.1001/jama.2016.0287 ↗
49. TNF/TNFR Axis promotes pyrin inflammasome activation and distinctly modulates pyrin inflammasomopathy10.1172/JCI121372 ↗
50. Inflammasome activation and regulation: toward A better understanding of complex mechanisms10.1038/s41421-020-0167-x ↗
51. Is caspase 1 central to activation of interleukin-1?10.1016/j.jbspin.2011.02.004 ↗
52. The chemistry of metal-organic frameworks for CO2 capture, regeneration and conversion10.1038/natrevmats.2017.45 ↗
53. A route to high surface area, porosity and inclusion of large molecules in crystals10.1038/nature02311 ↗
54. Rod, packings and metal-organic frameworks constructed from rod-shaped secondary building units10.1021/ja045123o ↗
55. Design, synthesis, structure, and gas (N2, Ar, CO2, CH4 and H2) sorption properties of porous metal-organic tetrahedral and heterocuboidal polyhedra10.1021/ja042802q ↗
56. A metal-organic framework with A hierarchical system of pores and tetrahedral building blocks10.1002/ange.200600175 ↗
57. Porous, crystalline, covalent organic frameworks10.1126/science.1120411 ↗
58. Gas adsorption sites in A large-pore metal-organic framework10.1126/science.1113247 ↗
59. Nanoparticles mimicking platelets and platelet cloaking10.1182/blood.2019002225 ↗
60. Core-shell noble-metal@ zeolitic-imidazolate-framework nanocarriers with high cancer treatment efficiency in vitro10.1039/C8TB03318H ↗
61. Evaluating UiO-66 metal-organic framework nanoparticles as acid-sensitive carriers for pulmonary drug delivery applications10.1021/acsami.0c10900 ↗
62. Biomimetic delivery of emodin via macrophage membrane-coated UiO-66-NH2 nanoparticles for acute pancreatitis treatment10.1016/j.bbrc.2024.149649 ↗
63. Anti-inflammatory effects of cajaninstilbene acid and its derivatives10.1021/acs.jafc.6b00227 ↗
64. Ability of malignant-associated pleural effusion on endothelial viability, motility, and angiogenesis in lung cancer
65. ENPP1 induces blood-brain barrier dysfunction and promotes brain metastasis formation in HER2-positive breast cancer
66. Serum MicroRNAs: -28-3p, -31-5p, -378a-3p, and -382-5p as novel potential biomarkers in acute lymphoblastic leukemia
67. Secondary immunodeficiency in hematological malignancies: focus on multiple myeloma and chronic lymphocytic leukemia
68. Anti-CD44 mAb for the treatment of B-cell chronic lymphocytic leukemia and other hematological malignancies: evaluation of WO201306349810.1517/13543776.2014.915942 ↗
69. In silico/in vitro hit-to-lead methodology yields SMYD3 inhibitor that eliminates unrestrained proliferation of breast carcinoma cells
70. Kiss1 inhibits the proliferation of nasopharyngeal carcinoma cells via activation of the LKB1/AMPK pathway10.3389/fonc.2021.724251 ↗
71. BRG1 activates proliferation and transcription of cell cycle-dependent genes in breast cancer cells10.3390/cancers12020349 ↗
72. Resolution of R-loops by INO80 promotes DNA replication and maintains cancer cell proliferation and viability10.1038/s41467-020-18306-x ↗
73. Genomic instability En route to and from cancer stem cells10.4161/cc.8.7.8041 ↗
74. Gene mutations in hereditary breast cancer-A review
75. Oncosuppressor-mutated cells as A liquid biopsy test for CancerScreening10.1038/s41598-019-38736-y ↗
76. Transforming growth factor-β1 activates ΔNp63/c-myc to promote oral squamous cell carcinoma
77. Hyaluronan in the cancer cells microenvironment10.3390/cancers15030798 ↗
78. Tumor microenvironment of cancer stem cells: perspectives on cancer stem cell targeting
79. Portrait of A Cancer: mutational signature analyses for cancer diagnostics
80. Szlasa · 2022 · vol. 13 · 1
81. Research progress on therapeutic targeting of quiescent cancer cells
82. Adoptive immunotherapy with engineered iNKT cells to target cancer cells and the suppressive microenvironment10.3389/fmed.2022.897750 ↗
83. Research progress on improving the efficiency of CDT by exacerbating tumor acidification10.2147/IJN.S366187 ↗
84. Current advances in photodynamic therapy (PDT) and the future potential of PDT-combinatorial cancer therapies10.3390/ijms25021023 ↗
85. UiO-66-NH2 as an effective solid support for quinazoline derivatives for antibacterial agents against gram-negative bacteria10.1039/D1NJ03749H ↗
86. Water-stable zirconium-based metal-organic frameworks armed polyvinyl alcohol nanofibrous membrane with enhanced antibacterial therapy for wound healing10.1016/j.jcis.2021.06.084 ↗
87. Cefazolin encapsulated UiO-66-NH2 nanoparticles enhance the antibacterial activity and biofilm inhibition against drug-resistant S. Aureus: in vitro and in vivo studies10.1016/j.cej.2022.140544 ↗
88. pH-responsive on-demand release of eugenol from metal-organic frameworks for synergistic bacterial killing
89. H2S-removing UiO-66 MOFs for sensitized antibacterial therapy10.1039/D3TB00552F ↗
90. A novel synergistic enzyme-antibiotic therapy with immobilization of mycobacteriophage LysinB enzyme onto Rif@UiO-66 nanocomposite for enhanced anti-TB nanotherapeutic; nanoenzybiotics approach
91. The preparation and characterization of UiO-66 metal-organic frameworks for the delivery of the drug ciprofloxacin and an evaluation of their antibacterial activities10.1039/C9NJ03216A ↗
92. Synthesis of UiO-66 loaded-caffeic acid and study of its antibacterial mechanism10.1016/j.foodchem.2022.134248 ↗
93. An NIR-II light-responsive nanoplatform for photothermal and enhanced photodynamic synergistic therapy toward drug-resistant bacterial infection and hypoxia relief in subcutaneous wound healing
94. Peroxidase- and UV-triggered oxidase mimetic activities of the UiO-66-NH2/chitosan composite membrane for antibacterial properties
95. Frustrated Lewis pair boosting photocatalytic antibacterial activity on PDI-bridged bimetallic UiO-66-NH210.1039/D3DT00788J ↗
96. Construction of UiO-NH2@TiC Schottky junction and their effectively photocatalytic and antibacterial performance10.1007/s10876-022-02233-6 ↗
97. Boosting antibacterial photodynamic therapy in a nanosized Zr MOF by the combination of Ag NP encapsulation and porphyrin doping10.1021/acs.inorgchem.3c01785 ↗
98. Ag-activated metal-organic framework with peroxidase-like activity synergistic Ag+ release for safe bacterial eradication and wound healing10.3390/nano12224058 ↗
99. Metal-organic framework modified MoS2 nanozyme for synergetic combating drug-resistant bacterial infections via photothermal effect and photodynamic modulated peroxidase-mimic activity10.1002/adhm.202101698 ↗
100. Au3+-Functionalized UiO-67 metal-organic framework nanoparticles: O2− and •OH generating nanozymes and their antibacterial functions